ASTERIAS BIOTHERAPEUTICS INC's ticker is AST and the CUSIP is 04624N107. A total of 63 filers reported holding ASTERIAS BIOTHERAPEUTICS INC in Q2 2015. The put-call ratio across all filers is 590.92 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2018 | $0 | -100.0% | 41 | -92.3% | 0.00% | – |
| Q3 2018 | $1,000 | 0.0% | 530 | -27.6% | 0.00% | – |
| Q2 2018 | $1,000 | – | 732 | +1162.1% | 0.00% | – |
| Q1 2018 | $0 | – | 58 | -68.1% | 0.00% | – |
| Q4 2017 | $0 | -100.0% | 182 | -92.2% | 0.00% | – |
| Q3 2017 | $8,000 | – | 2,336 | +4667.3% | 0.00% | – |
| Q2 2017 | $0 | -100.0% | 49 | -94.1% | 0.00% | – |
| Q1 2017 | $3,000 | -57.1% | 828 | -43.5% | 0.00% | – |
| Q4 2016 | $7,000 | – | 1,465 | +3473.2% | 0.00% | – |
| Q3 2016 | $0 | – | 41 | -76.4% | 0.00% | – |
| Q2 2016 | $0 | -100.0% | 174 | 0.0% | 0.00% | – |
| Q1 2016 | $1,000 | 0.0% | 174 | -19.4% | 0.00% | – |
| Q4 2015 | $1,000 | -75.0% | 216 | -79.8% | 0.00% | – |
| Q3 2015 | $4,000 | +300.0% | 1,071 | +398.1% | 0.00% | – |
| Q2 2015 | $1,000 | 0.0% | 215 | -21.0% | 0.00% | – |
| Q1 2015 | $1,000 | -50.0% | 272 | -51.7% | 0.00% | – |
| Q4 2014 | $2,000 | – | 563 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BROADWOOD CAPITAL INC | 1,641,025 | $7,549,000 | 1.29% |
| Squarepoint Ops LLC | 10,200 | $47,000 | 0.02% |
| DELTEC ASSET MANAGEMENT LLC | 15,000 | $69,000 | 0.02% |
| FIRST NEW YORK SECURITIES LLC /NY | 5,700 | $26,220,000 | 0.01% |
| WEDBUSH SECURITIES INC | 11,033 | $51,000 | 0.01% |
| Allen Investment Management, LLC | 15,524 | $71,000 | 0.01% |
| Tower Research Capital LLC (TRC) | 14,512 | $67,000 | 0.01% |
| A.R.T. Advisors, LLC | 19,216 | $88,000 | 0.00% |
| MILLENNIUM MANAGEMENT LLC | 134,102 | $617,000 | 0.00% |
| HIGHBRIDGE CAPITAL MANAGEMENT LLC | 17,105 | $79,000 | 0.00% |